antioxidants and specifies having wholesome eating habits. It aims to support the ovaries in creating the elements necessary for the production of new eggs and the proper function of the existing egg cells and endocrine hormone producing cells. Which women is the ovarian rejuvenation programme re - commended for? “We apply the SEGO pro - gramme in cases of reduced fer - tility caused by a decreased fun - ction and quality of the ovaries, to those patients with a poor res - ponse to stimulation during the process of in vitro fertilization, as well as the impossibility of obta - ining egg cells and their fertiliza - tion, during a spontaneous cyc - le. Another group of patients are those in the postmenopausal pe - riod or perimenopause. Those are women aged between 40 and 50. How much does this tre - atment increase the chances that a woman will become pregnant after treatment? “More than three-quarters of patients involved in the ovarian rejuvenation programme, after a period of six months, experience a significant improvement in the - ir function, hormone producti - on, and an increased number and quality of egg cells and embryos. There are clinical pregnancies af - ter the application of ovary reju - venation.
titled SEGO, which corrects va - rious mechanisms that cause fa - ilure of ovarian function. The programme has several parts and leads to the creation of high-qua - lity egg cells, as well as to an im - proved quality of life - says Pro - fessor Dr Ljubić, asserting that SEGO is a therapeutic method, but also has a preventive role. The SEGO method consists of several separate procedures in - tegrated in a common project ai - med to support, increase or crea - te elements necessary for normal ovarian function: Stem cell the - rapy - cell therapy which uses stem cells obtained from the pa - tient's own body. The aim of this therapy is to create new or inci - te existing non-differentiated ova - rian stem cells - which are to be developed into new oocytes and hormone-producing cells. Ener - gy mitochondrial boosting - boo - sting mitochondrial energy pro - duction of ovarian cells with a specific physical exercise regime. Growth factor PLPR therapy – control mechanisms usually con - sist of different growth factors. These growth factors are obtai - ned from the patient’s own blo - od. Inside the ovary, they control the creation and growth of eggs and the surrounding cells respon - sible for hormone production. Oral adjuvant therapy: this part of the program includes taking particular supplements, vitamins,
Professor Dr Aleksandar Ljubić is a gynaecologist and obstetrician at the largest priva - te health care group in Serbia, “MediGroup”. He has devoted his rich, three-decade-long scien - tific career to female reproducti - ve health. Together with a team of professional associates, he has performed thousands of assi - sted fertilization procedures of different types, births, as well as high-risk pregnancies. Professor Dr Ljubić enjoys the status of one of the top experts in the region and the world. He was elected deputy secretary of the World Association of Perinatal Medicine and he is a visiting professor at Cornell University in New York. Professor Ljubić has caused a real scientific sensation with the introduction of SEGO met - hods. Together with his team in MediGroup hospital Jevremova, he has spent several years deve - loping a method which can be simply explained as ovarian re - juvenation. In a short conversation with professor Ljubić we found out that the purpose of the new met - hod is to increase and mainta - in female reproductive potential, improve their quality of life, po - stpone menopause and prevent diseases related to the cessation of ovarian function. “This is the first integrative, comprehensive programme, en -
| 67
Made with FlippingBook interactive PDF creator